Presentation Information
[LS9-2]Tofersen Paves the Way for a New Treatment Strategy for SOD1-ALS
Seiichi Nagano1,2 (1. Department of Neurodevelopmental and Neurodegenerative Disease Research, United Graduate School of Child Development, The University of Osaka, 2. Department of Neurology, Graduate School of Medicine, The University of Osaka)
Password required to view
Log in
or